460 related articles for article (PubMed ID: 25796565)
1. Aberrant protein S-nitrosylation contributes to the pathophysiology of neurodegenerative diseases.
Nakamura T; Prikhodko OA; Pirie E; Nagar S; Akhtar MW; Oh CK; McKercher SR; Ambasudhan R; Okamoto S; Lipton SA
Neurobiol Dis; 2015 Dec; 84():99-108. PubMed ID: 25796565
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
3. S-nitrosylation of critical protein thiols mediates protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
Nakamura T; Lipton SA
Antioxid Redox Signal; 2011 Apr; 14(8):1479-92. PubMed ID: 20812868
[TBL] [Abstract][Full Text] [Related]
4. Aberrant protein s-nitrosylation in neurodegenerative diseases.
Nakamura T; Tu S; Akhtar MW; Sunico CR; Okamoto S; Lipton SA
Neuron; 2013 May; 78(4):596-614. PubMed ID: 23719160
[TBL] [Abstract][Full Text] [Related]
5. Redox modulation by S-nitrosylation contributes to protein misfolding, mitochondrial dynamics, and neuronal synaptic damage in neurodegenerative diseases.
Nakamura T; Lipton SA
Cell Death Differ; 2011 Sep; 18(9):1478-86. PubMed ID: 21597461
[TBL] [Abstract][Full Text] [Related]
6. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
Uehara T; Nakamura T; Yao D; Shi ZQ; Gu Z; Ma Y; Masliah E; Nomura Y; Lipton SA
Nature; 2006 May; 441(7092):513-7. PubMed ID: 16724068
[TBL] [Abstract][Full Text] [Related]
7. Protein S-Nitrosylation as a Therapeutic Target for Neurodegenerative Diseases.
Nakamura T; Lipton SA
Trends Pharmacol Sci; 2016 Jan; 37(1):73-84. PubMed ID: 26707925
[TBL] [Abstract][Full Text] [Related]
8. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases.
Gu Z; Nakamura T; Lipton SA
Mol Neurobiol; 2010 Jun; 41(2-3):55-72. PubMed ID: 20333559
[TBL] [Abstract][Full Text] [Related]
9. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding.
Nakamura T; Lipton SA
Cell Death Differ; 2007 Jul; 14(7):1305-14. PubMed ID: 17431424
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Proteomic Approaches for Analysis of Protein S-Nitrosylation.
Qu Z; Greenlief CM; Gu Z
J Proteome Res; 2016 Jan; 15(1):1-14. PubMed ID: 26544640
[TBL] [Abstract][Full Text] [Related]
11. Nitrosative stress in the ER: a new role for S-nitrosylation in neurodegenerative diseases.
Benhar M; Forrester MT; Stamler JS
ACS Chem Biol; 2006 Jul; 1(6):355-8. PubMed ID: 17163772
[TBL] [Abstract][Full Text] [Related]
12. Dysfunctional Mitochondrial Dynamics in the Pathophysiology of Neurodegenerative Diseases.
Haun F; Nakamura T; Lipton SA
J Cell Death; 2013; 6():27-35. PubMed ID: 24587691
[TBL] [Abstract][Full Text] [Related]
13. Nitrosative Stress in the Nervous System: Guidelines for Designing Experimental Strategies to Study Protein S-Nitrosylation.
Nakamura T; Lipton SA
Neurochem Res; 2016 Mar; 41(3):510-4. PubMed ID: 26118537
[TBL] [Abstract][Full Text] [Related]
14. Protein Transnitrosylation Signaling Networks Contribute to Inflammaging and Neurodegenerative Disorders.
Nakamura T; Oh CK; Zhang X; Tannenbaum SR; Lipton SA
Antioxid Redox Signal; 2021 Sep; 35(7):531-550. PubMed ID: 33957758
[No Abstract] [Full Text] [Related]
15. Emerging roles of S-nitrosylation in protein misfolding and neurodegenerative diseases.
Nakamura T; Lipton SA
Antioxid Redox Signal; 2008 Jan; 10(1):87-101. PubMed ID: 17961071
[TBL] [Abstract][Full Text] [Related]
16. Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.
Nakamura T; Lipton SA
Apoptosis; 2010 Nov; 15(11):1354-63. PubMed ID: 20177970
[TBL] [Abstract][Full Text] [Related]
17. Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases.
Nakamura T; Cho DH; Lipton SA
Exp Neurol; 2012 Nov; 238(1):12-21. PubMed ID: 22771760
[TBL] [Abstract][Full Text] [Related]
18. Cysteine 343 in the substrate binding domain is the primary S-Nitrosylated site in protein disulfide isomerase.
Ogura J; Ruddock LW; Mano N
Free Radic Biol Med; 2020 Nov; 160():103-110. PubMed ID: 32768572
[TBL] [Abstract][Full Text] [Related]
19. [Regulation of Unfolded Protein Response via Protein S-nitrosylation].
Ohkubo Y; Nakato R; Uehara T
Yakugaku Zasshi; 2016; 136(6):801-4. PubMed ID: 27252058
[TBL] [Abstract][Full Text] [Related]
20. Nitric Oxide-Mediated Posttranslational Modifications: Impacts at the Synapse.
Bradley SA; Steinert JR
Oxid Med Cell Longev; 2016; 2016():5681036. PubMed ID: 26635909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
